Scientific Information Research
Keywords
antitumor drugs; innovation source ability; patent information; patent analysis
Abstract
[Purpose/significance]Through the analysis of Shanghai's anti-tumor drug patent information,it provides valuable decision-making and strategic support for the implementation of innovative activities and future development of the Shanghai biomedical industry.[Method/process]Carry out information mining and description of Shanghai's anti-cancer drug patents,and explore the innovation capabilities of Shanghai's anti-cancer drugs from the three aspects of high-level patents,scientific innovation community,and patent achievement transformation,and understand the development context of innovation strategies.[Result/conclusions The research results show that to improve Shanghai's scientific and technological innovation ability,it is necessary to increase high-level patent output,coordinate the development of regional innovation communities,improve the transformation of patent achievements,and provide effective guarantees for technological innovation.
First Page
94
Recommended Citation
BAO, Na and XU, Xin
(2021)
"Patent Analysis of Shanghai Antitumor Drugs and Research on the Sources of Innovation Strategies,"
Scientific Information Research: Vol. 3:
Iss.
1, Article 6.
Available at:
https://eng.kjqbyj.com/journal/vol3/iss1/6
Reference
[1] 上海市人民政府新闻办公室.上海加快建设具有全球影响力的科技创新中心五年以来的主要进展[DB/OL].(2019-05-21)[2020-08-17]http://www.shio.gov.cn/sh/xwb/n790/n792/n1070/n1079/u1ai21124.html. [2] 李杨,唐克.全球主要经济体技术创新及对我国的启示:基于PCT申请视角[J].征信,2020,38(08):11-17,92. [3] 陈超.如何理解创新策源能力[J].竞争情报,2018,14(04):3. [4] 任声策.以“源”促“策”,全面增强创新策源能力[N].科技日报,2020-03-24(005). [5] 朱梦菲,陈守明,邵悦心.基于AHP-TOPSIS和SOM聚类的区域创新策源能力评价[J].科研管理,2020,41(02):40-50. [6] 冯海刚.从专利角度分析和展望我国固体废物产业的技术创新[J].中国发明与专利,2020,17(06):70-77. [7] 黄辛,胡璇子.15大城市科技创新策源点出炉[J].中国科技奖励,2019(06):70-72. [8] 江胜强,田培培,沙子墨,等.基于合作发明专利的我国生物医药领域研发合作现状分析[J].中国药房,2017,28(31):4334-4337. [9] 戈一冰,马路.基于专利视角的我国高等医学院校科技创新能力分析[J].中华医学图书情报杂志,2019,28(04):10-15. [10] 李悦,高欢,金芳,等.多肽类化合物抗肿瘤作用机制的研究进展[J].医学综述,2019,25(17):3486-3490,3496. [11] 代月函,杨琳琳,靳春鹏,等.抗CD47抗体、多肽类抗肿瘤药物专利发展状况分析[J].中国新药杂志,2019,28(19):2305-2311.